FDA Approves IBS-C Treatment Linzess (IRWD) (FRX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
UPDATE: Ironwood (IRWD), Forest (FRX) Win FDA Approval for Linzess
August 30, 2012 10:58 AM EDT(Updated - August 30, 2012 10:59 AM EDT)
Ironwood Pharmaceuticals (NASDAQ: IRWD), Forest Labs (NYSE: FRX) win FDA approval for Linzess to treat irritable bowel. (NOTE: Shares of IRWD were halted)... More



